Jun 19

TOBI 2014 Highlights & Orthobiologics Trends

The Orthobiologic Institute PRP and Regenerative Medicine Symposium for 2014 is officially over. And this year was by far the most successful and exciting symposium to date. The 5th Annual TOBI: The Orthobiologic Institute continues its growth, with nearly 300 in attendance and over 100 people streaming the conference live on the internet, while featuring more international attendees than ever before. Doctors from 18 different countries converged on the Red Rocks Casino in Las Vegas, traveling from Australia, Brazil, Canada,...

May 27

Contraindications for PRP Injections?: A Case Report of Chronic Anti-platelet Therapy

A recent case report published in the European Review for Medical and Pharmacological Sciences examines the effects of intra-articular PRP injections in a patient on chronic anti-platelet therapy. The study was published by researchers out of the Rizolli institute in Balogna, Italy, and includes 2014 TOBI: The Orthobiologic Institute speaker Dr. Elizaveta Kon. The patient is a 52 year old male runner complaining of consistent left knee pain, associated with significant functional impairments and complete withdrawal from sporting activity for...

May 20

Outcomes of Prolotherapy in Chondromalacia Patella Patients: Improvements in Pain Level and Function

Chondromalacia patella (CMP), also more commonly referred to as patellofemoral pain syndrome, has classically been identified as one of the resultant factors towards osteoarthritis (OA). CMP is a product of inflammation and progressive degradation and thinning of cartilage underneath the patella which results in mild to severe chronic pain around the knee cap, stiffness and crepitation, along with exacerbation of pain upon physical activities such as climbing stairs, running and squatting. The cause of CMP range from various age groups...